Vignesh Rajah - 15 Nov 2022 Form 4 Insider Report for Y-mAbs Therapeutics, Inc. (YMAB)

Role
SVP & CMO
Signature
/s/ Vignesh Rajah
Issuer symbol
YMAB
Transactions as of
15 Nov 2022
Net transactions value
+$5,884
Form type
4
Filing time
16 Nov 2022, 18:01:03 UTC
Previous filing
28 Apr 2022
Next filing
19 Jan 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction YMAB Common Stock Purchase $5,884 +1,195 +39% $4.92 4,266 15 Nov 2022 Spouse and minor F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 4,033 shares of common stock owned by Reporting Person's spouse and 233 held by Reporting Person's minor child. Reporting Person may be deemed to have a pecuniary interest in the securities due to family relationship.
F2 Reporting Person disclaims beneficial ownership of the securities reported and this report shall not be deemed an admission that Reporting Person is the beneficial owner of such securities for purposes of Section 16 of the Securities Exchange Act, as amended, or for any other purpose.